Phase 2 Trial of Zanzalintinib in Advanced Bone Sarcomas Initiated
A Phase 2 trial is underway to evaluate the efficacy of zanzalintinib monotherapy in patients with advanced or metastatic bone sarcomas.
Therapeutic Area
Therapeutic area intelligence for Bone Sarcoma with 1 indexed intelligence signal across regulatory, clinical, competitive, and market developments.
No related entities indexed yet.
No catalysts indexed for this entity yet.
No related entities indexed yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.